ANUSOL

This brand name is authorized in Australia, Ireland, United Kingdom

Active ingredients

The drug ANUSOL contains a combination of these active pharmaceutical ingredients (APIs):

1 Zinc UNII SOI2LOH54Z - ZINC OXIDE

Zinc blocks the intestinal absorption of copper from the diet and the reabsorption of endogenously secreted copper. Zinc induces the production of metallothionein in the enterocyte, a protein that binds copper thereby preventing its transfer into the blood. The bound copper is then eliminated in the stool following desquamation of the intestinal cells. Read about Zinc

2 Balsam Peru UNII 8P5F881OCY - BALSAM PERU

3 Bismuth oxide UNII A6I4E79QF1 - BISMUTH OXIDE

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C05AX04	Zinc preparations	C Cardiovascular system → C05 Vasoprotectives → C05A Agents for treatment of hemorrhoids and anal fissures for topical use → C05AX Other agents for treatment of hemorrhoids and anal fissures for topical use
Discover more medicines within C05AX04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 4039N, 4040P
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 20736, 20738